| Description | Blinatumomab (formerly known as Anatumomab) is a bispecific monoclonal antibody that specifically targets the CD19 antigen on B cells and is utilized in the study of acute lymphoblastic leukemia [1]. |
| Synonyms | Anatumomab |
| molecular weight | N/A |
| CAS | 853426-35-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |